Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Fulfilling the Gap: Innovative Critical Reagents for Non-Human Primate Preclinical Studies
Watch to learn the tools that can support more accurate immune profiling and biomarker analysis in NHP-based preclinical research.
Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
In this webinar, experts explore how high-quality biospecimens, longitudinal data, and regulatory rigor drive the future of biomarker discovery and clinical diagnostics.
Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance
In this webinar, three experts discuss best practices for ensuring specimen integrity, leveraging biobanking for oncology breakthroughs, and enriching clinical data for translational research.
Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies
Learn how enhanced CDX models with humanized immune systems improve preclinical-to-clinical success in emerging immuno-oncology therapies.
Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection
Learn how AI is advancing preclinical research through quantitative pathology, curated biospecimen data, and intelligent tumor model selection in this expert-led webinar.
Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Join us for an in-depth exploration of immunohistochemistry (IHC) in the first installment of our comprehensive webinar series with Precision for Medicine.
Visual Function with Aging in Normal and Alzheimer’s Disease Model Mice
In this presentation, Anna Matynia, PhD explains the effect of normal aging and Alzheimer’s Disease on visual acuity, contrast sensitivity, and pupillary light reflex as a possible early biomarker for Alzheimer’s Disease.
#ExpertAnswers: Arutha Kulasinghe on Single-Cell Spatial Phenotyping for Biomarker Discovery
Dr. Arutha Kulasinghe discusses application of single-cell spatial phenotyping for characterizing the tumor microenvironment.
#ExpertAnswers: Jeffrey Silva and Matthew Stokes on Mass Spectrometry-Based Proteomics
Experts from Cell Signaling Technology answer questions from a recent webinar on mass spectrometry-based proteomics.
Spatial Phenotyping: A Revolutionary Approach to Biomarker Discovery for Cancer Immunotherapy
Dr. Arutha Kulasinghe discusses the potential of single-cell spatial phenotyping in biomarker analysis and how it can be used to characterize tumor microenvironments.
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
In this Q&A Report, experts discuss isolation methods, sample selection, testing techniques, and future applications of cell-free plasma samples for cancer diagnostics and treatment
Cutting Edge Conversations: Biomarkers – Challenges and Opportunities
The 5th and final episode in the Cutting Edge Conversation series for 2021 features Dr. Morad Nakhleh, Natalie Smith, and Dr. Bhavika Patel as they discuss industry challenges and innovations surrounding biomarkers in life science research and precision medicine
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.













